Evotec: A High-Risk, High-Reward Turnaround in Drug Discovery Services Anchored by Strategic Partnerships and Platform Innovation
Overview
Evotec SE is a Germany-based leader in outsourced drug discovery and development, delivering integrated R&D solutions across small molecules, biologics, and cell therapies through innovative technologies like AI-driven design and iPSC disease modeling. Serving all top 20 pharmas and hundreds of biotechs, Evotec’s two core divisions – Discovery & Preclinical Development and Just – Evotec Biologics – generate revenue via contracted services, long-term partnerships, milestone payments, and prospective royalties. With a pipeline exceeding 100 co-owned assets and deep therapeutic area expertise, Evotec acts as a ‘drug discovery platform’ accelerating clients from concept to cure.